Patients with hepatocellular carcinoma near the end of life: A longitudinal qualitative study of their illness experiences

Lissi Hansen, Susan J. Rosenkranz, Gina Vaccaro, Michael F. Chang

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Background: In the United States, the incidence of hepatocellular carcinoma (HCC) is rising. For those diagnosed with terminal HCC, there is no curative treatment and duration of survival is typically 1 to 2 years. Research on illness and treatment experiences toward the end of life for patients with terminal HCC is limited. Objective: The aim of this study was to explore the illness experiences of patients with terminal HCC as they approached the end of life. Methods: This study used a prospective, longitudinal descriptive design. Interview data were collected from 14 patients once a month for up to 6 months, for a total of 45 interviews. Data were analyzed using conventional content analysis. Results: Three major themes (illness perceptions, decision to start treatment, and navigating treatment over time) and 10 subthemes were identified that were reflected across time in all patient experiences. Patients faced challenges with symptom experiences, treatment decisions, and unmet information needs affecting their quality of life. Conclusions: Gaining knowledge about the challenges facing patients with HCC is crucial for designing interventions that optimize their quality of life. Implications for Practice: Healthcare professionals may improve the quality of life of patients with terminal HCC by eliciting patients' perceptions of their illness and treatment decisions, symptom experiences, and information needs as the disease progresses and providing symptom management and offering information tailored to their needs. Care for patients with HCC who are approaching the end of life should be multidisciplinary and include timely referral to palliative care.

Original languageEnglish (US)
Pages (from-to)E19-E27
JournalCancer Nursing
Volume38
Issue number4
DOIs
StatePublished - Jul 2 2015

Fingerprint

Longitudinal Studies
Hepatocellular Carcinoma
Quality of Life
Therapeutics
Interviews
Information Management
Professional Practice
Palliative Care
Patient Care
Referral and Consultation
Delivery of Health Care
Survival
Incidence
Research

Keywords

  • Adult population
  • Cancer
  • End of life
  • Liver
  • Qualitative research

ASJC Scopus subject areas

  • Oncology
  • Oncology(nursing)

Cite this

Patients with hepatocellular carcinoma near the end of life : A longitudinal qualitative study of their illness experiences. / Hansen, Lissi; Rosenkranz, Susan J.; Vaccaro, Gina; Chang, Michael F.

In: Cancer Nursing, Vol. 38, No. 4, 02.07.2015, p. E19-E27.

Research output: Contribution to journalArticle

@article{dd7ea3419fe14e02adf8bb59db8c0dee,
title = "Patients with hepatocellular carcinoma near the end of life: A longitudinal qualitative study of their illness experiences",
abstract = "Background: In the United States, the incidence of hepatocellular carcinoma (HCC) is rising. For those diagnosed with terminal HCC, there is no curative treatment and duration of survival is typically 1 to 2 years. Research on illness and treatment experiences toward the end of life for patients with terminal HCC is limited. Objective: The aim of this study was to explore the illness experiences of patients with terminal HCC as they approached the end of life. Methods: This study used a prospective, longitudinal descriptive design. Interview data were collected from 14 patients once a month for up to 6 months, for a total of 45 interviews. Data were analyzed using conventional content analysis. Results: Three major themes (illness perceptions, decision to start treatment, and navigating treatment over time) and 10 subthemes were identified that were reflected across time in all patient experiences. Patients faced challenges with symptom experiences, treatment decisions, and unmet information needs affecting their quality of life. Conclusions: Gaining knowledge about the challenges facing patients with HCC is crucial for designing interventions that optimize their quality of life. Implications for Practice: Healthcare professionals may improve the quality of life of patients with terminal HCC by eliciting patients' perceptions of their illness and treatment decisions, symptom experiences, and information needs as the disease progresses and providing symptom management and offering information tailored to their needs. Care for patients with HCC who are approaching the end of life should be multidisciplinary and include timely referral to palliative care.",
keywords = "Adult population, Cancer, End of life, Liver, Qualitative research",
author = "Lissi Hansen and Rosenkranz, {Susan J.} and Gina Vaccaro and Chang, {Michael F.}",
year = "2015",
month = "7",
day = "2",
doi = "10.1097/NCC.0000000000000188",
language = "English (US)",
volume = "38",
pages = "E19--E27",
journal = "Cancer Nursing",
issn = "0162-220X",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Patients with hepatocellular carcinoma near the end of life

T2 - A longitudinal qualitative study of their illness experiences

AU - Hansen, Lissi

AU - Rosenkranz, Susan J.

AU - Vaccaro, Gina

AU - Chang, Michael F.

PY - 2015/7/2

Y1 - 2015/7/2

N2 - Background: In the United States, the incidence of hepatocellular carcinoma (HCC) is rising. For those diagnosed with terminal HCC, there is no curative treatment and duration of survival is typically 1 to 2 years. Research on illness and treatment experiences toward the end of life for patients with terminal HCC is limited. Objective: The aim of this study was to explore the illness experiences of patients with terminal HCC as they approached the end of life. Methods: This study used a prospective, longitudinal descriptive design. Interview data were collected from 14 patients once a month for up to 6 months, for a total of 45 interviews. Data were analyzed using conventional content analysis. Results: Three major themes (illness perceptions, decision to start treatment, and navigating treatment over time) and 10 subthemes were identified that were reflected across time in all patient experiences. Patients faced challenges with symptom experiences, treatment decisions, and unmet information needs affecting their quality of life. Conclusions: Gaining knowledge about the challenges facing patients with HCC is crucial for designing interventions that optimize their quality of life. Implications for Practice: Healthcare professionals may improve the quality of life of patients with terminal HCC by eliciting patients' perceptions of their illness and treatment decisions, symptom experiences, and information needs as the disease progresses and providing symptom management and offering information tailored to their needs. Care for patients with HCC who are approaching the end of life should be multidisciplinary and include timely referral to palliative care.

AB - Background: In the United States, the incidence of hepatocellular carcinoma (HCC) is rising. For those diagnosed with terminal HCC, there is no curative treatment and duration of survival is typically 1 to 2 years. Research on illness and treatment experiences toward the end of life for patients with terminal HCC is limited. Objective: The aim of this study was to explore the illness experiences of patients with terminal HCC as they approached the end of life. Methods: This study used a prospective, longitudinal descriptive design. Interview data were collected from 14 patients once a month for up to 6 months, for a total of 45 interviews. Data were analyzed using conventional content analysis. Results: Three major themes (illness perceptions, decision to start treatment, and navigating treatment over time) and 10 subthemes were identified that were reflected across time in all patient experiences. Patients faced challenges with symptom experiences, treatment decisions, and unmet information needs affecting their quality of life. Conclusions: Gaining knowledge about the challenges facing patients with HCC is crucial for designing interventions that optimize their quality of life. Implications for Practice: Healthcare professionals may improve the quality of life of patients with terminal HCC by eliciting patients' perceptions of their illness and treatment decisions, symptom experiences, and information needs as the disease progresses and providing symptom management and offering information tailored to their needs. Care for patients with HCC who are approaching the end of life should be multidisciplinary and include timely referral to palliative care.

KW - Adult population

KW - Cancer

KW - End of life

KW - Liver

KW - Qualitative research

UR - http://www.scopus.com/inward/record.url?scp=84934435948&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84934435948&partnerID=8YFLogxK

U2 - 10.1097/NCC.0000000000000188

DO - 10.1097/NCC.0000000000000188

M3 - Article

C2 - 25122134

AN - SCOPUS:84934435948

VL - 38

SP - E19-E27

JO - Cancer Nursing

JF - Cancer Nursing

SN - 0162-220X

IS - 4

ER -